Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis.
about
Clinical Glycomics Employing Graphitized Carbon Liquid Chromatography-Mass SpectrometryQuantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans.Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes.BlotGlycoABCTM, an integrated glycoblotting technique for rapid and large scale clinical glycomics.Mass spectrometric profiling of N-linked oligosaccharides and uncommon glycoform in mouse serum with head and neck tumor.Secondary disorders of glycosylation in inborn errors of fructose metabolism.Detection of hepatocellular carcinoma using glycomic analysis.The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome.High-mannose glycans are elevated during breast cancer progressionN-glycans in liver-secreted and immunoglogulin-derived protein fractions.N- and O-linked glycosylation of total plasma glycoproteins in galactosemia.'Bobo-Newton syndrome': An unwanted gift from man's best friend.Real-time single-molecule coimmunoprecipitation of weak protein-protein interactions.Liver disease and HPLC quantification of disialotransferrin for heavy alcohol use: a case seriesSite-specific N-glycosylation analysis of human factor XI: Identification of a noncanonical NXC glycosite.Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry.Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers.Profile of native N-linked glycan structures from human serum using high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry.BMI but not stage or etiology of nonalcoholic liver disease affects the diagnostic utility of carbohydrate-deficient transferrin.N-linked glycosylation of the liver cancer biomarker GP73Glycosylation and liver cancer.N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma.Online enzymatic sequencing of glycans from Trastuzumab by phospholipid-assisted capillary electrophoresis.N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus.Serum protein fractionation using supported molecular matrix electrophoresis.
P2860
Q27024150-252B4404-0724-488A-BAE2-CDCC9CC0CC88Q33285593-CAAA4A2E-E4E0-4DC3-803F-D118EA456971Q33292639-24AD8B37-4CAE-418C-80B8-E8F4BC54F47EQ33305172-6E5F9679-2B02-48EB-A109-41732B3283DBQ33324569-4CE9ED10-F005-4732-BF07-8D72E6CB8541Q33386314-B5A34135-7DAB-4924-98C2-43B0801A4E4DQ33410061-C5439797-A21D-4714-98CA-D624988E6382Q33447457-4F533EB2-8BBC-453D-B59F-13687190BF81Q33753523-148B9893-9A8C-41C3-AB45-F6F95E193F27Q34156760-D6F19569-9235-4312-8A1D-3BD964E549E0Q34320339-3EDD7B07-05AC-431E-9531-EA1523859646Q34659423-06AA579F-0E61-4F19-8936-14ED51BFFC9BQ35000412-C2B6B50F-2D30-49C5-A753-D74471C7C201Q35047427-0D11C9CF-3D42-41A4-9AC9-F5EBA5118FEBQ35219258-3CC45C9E-7B8A-4113-9219-16BB0D42264CQ35821161-110A0C41-C12F-4020-82EC-F6A924D673BAQ35902976-DB260935-8339-4722-9AA1-0DE8984EEF61Q37396485-6ABF581A-3A2E-47B1-910B-2281E6D29CB6Q38123193-BEC3B22E-A969-4DEE-8635-4EB3A765096FQ38296442-ABA842B0-6668-4F4E-9BFC-669D20291B47Q38366329-862B0A69-667B-4B5F-9085-47B62D7A76FBQ43244550-D2C5AF55-41A7-43D5-B610-AB55555C3022Q44970905-F2CB74B6-A3CE-4CC5-952F-3E67DBAD78D8Q45401312-0553EB85-A7A0-478C-A3D6-48D654AEE0F8Q50232333-55BC3A75-0ED1-4A53-BC73-0D07C65BFFFB
P2860
Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Mass spectrometric approach fo ...... ses: application to cirrhosis.
@ast
Mass spectrometric approach fo ...... ses: application to cirrhosis.
@en
type
label
Mass spectrometric approach fo ...... ses: application to cirrhosis.
@ast
Mass spectrometric approach fo ...... ses: application to cirrhosis.
@en
prefLabel
Mass spectrometric approach fo ...... ses: application to cirrhosis.
@ast
Mass spectrometric approach fo ...... ses: application to cirrhosis.
@en
P2093
P50
P356
P1433
P1476
Mass spectrometric approach fo ...... ases: application to cirrhosis
@en
P2093
André Klein
Jean-Claude Michalski
Willy Morelle
P304
P356
10.1093/GLYCOB/CWJ067
P577
2005-12-08T00:00:00Z